The glycated albumin to glycated haemoglobin ratio increases along with the fibrosis stage in non-alcoholic steatohepatitis

Annals of Clinical Biochemistry

Volumn 49, Issue 4, 2012, Pages 387-390

  Bando, Yukihiro ^a   Kanehara, Hideo ^a   Aoki, Keiko ^a   Toya, Daishy ^a   Notsumata, Kazuo ^a   Tanaka, Nobuyoshi ^a   Enomoto, Hirayuki ^b   Nakasho, Keiji ^b   Nakamura, Hideji ^c   Kasayama, Soji ^c   Koga, Masafumi ^d  

^a FUKUI KEN SAISEIKAI HOSPITAL   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c NISSAY HOSPITAL   (Japan)

^d Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED ALBUMIN; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LIVER FUNCTION TEST; MALE; NONALCOHOLIC FATTY LIVER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT;

ADULT; ALBUMINS; FATTY LIVER; FEMALE; GLUCOSE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

EID: 84867136074     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1258/acb.2012.011139     Document Type: Article

References (29)

1. Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007;22:778-87
2. Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 2007;22:788-93
3. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9
4. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43(Suppl 1):S99-112
5. Cohen MP. Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy? J Diabet Complications 1998;2:214-7
6. Ic in diabetes mellitus. N Engl J Med 1976;295:417-20
7. Bunn HF, Gabbay KH, Gallop PM. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978;20:21-7
8. Jeffcoate SL. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabetic Med 2004;21:657-65
9. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001;47:153-63
10. Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes JW. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 1979;76:4258-61
11. Koga M, Kasayama S. Clinical impact of glycated albumin as an another glycemic control marker. Endocr J 2010;57:751-62
12. Koga M, Matsumoto S, Saito H, Kasayama S. Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients. Endocr J 2006;53:387-91
13. Koga M, Otsuki M, Matsumoto S, Saito H, Mukai M, Kasayama S. Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clin Chim Acta 2007;378:48-52
14. Koga M, Saito H, Mukai M, Otsuki M, Kasayama S. Serum glycated albumin levels are influenced by smoking status, independent of plasma glucose levels. Acta Diabetol 2009;46:141-4
15. Koga M, Murai J, Saito H, Mukai M, Kasayama S. Serum glycated albumin, but not glycated hemoglobin, is low in relation to glycemia in hyperuricemic men. Acta Diabetol 2010;47:173-7
16. Koga M, Murai J, Saito H, Mukai M, Kasayama S. Serum glycated albumin, but not glycated hemoglobin, is low in relation to glycemia in men with hypertriglyceridemia. J Diabetes Invest 2010;1:202-7
17. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Haffner SM. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 2005;54:3140-7
18. Oh SY, Cho YK, Kang MS, et al. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 2006;55:1604-9
19. Koga M, Murai J, Saito H, Mukai M, Kasayama S. Serum glycated albumin levels, but not glycated hemoglobin, is low in relation to glycemia in non-diabetic men with nonalcoholic fatty liver disease with high alanine aminotransferase levels. Clin Biochem 2010;43:1023-5
20. Cacciatore L, Cozzolino G, Giardina MG, et al. Abnormalities of glucose metabolism induced by liver cirrhosis and glycosylated hemoglobin levels in chronic liver disease. Diabetes Res 1988;7:185-8
21. Nomura Y, Nanjo K, Miyano M, et al. Hemoglobin A1 in cirrhosis of the liver. Diabetes Res 1989;11:177-80
22. Stefanovic S, Bosnjakovic V, Stajnfl S, Vujnic V, Petric J, Ristic M. Characteristics of albumin turnover in different stages of cirrhosis of liver evaluated by means of radioisotope technique and analog computer analysis. Radiobio Radiother 1972;13:105-11
23. 1c as a novel indicator for estimation of mean plasma glucose in the patients with chronic liver disease. Diabetes Res Clin Pract 2008;81:258-62
24. 1c ratio with hepatic function tests in patients with chronic liver disease. Ann Clin Biochem 2009;46:368-72
25. Brunt EM, Janney CG, Di Biscegli AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74
26. 1c. I: comparison of Japan Diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories. Ann Clin Biochem 2005;42:41-6
27. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 2010;1:212-28
28. Kouzuma T, Usami T, Yamakoshi M, Takahashi M, Imamura S. An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta 2004;324:61-71
29. Das I. Raised C-reactive protein levels in serum from smokers. Clin Chem Acta 1985;153:9-13